A detailed history of Disciplina Capital Management LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Disciplina Capital Management LLC holds 19 shares of MRNA stock, worth $984. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19
Previous 165 88.48%
Holding current value
$984
Previous $19.6 Million 93.52%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$63.64 - $125.14 $9,291 - $18,270
-146 Reduced 88.48%
19 $1.27 Million
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $15,907 - $20,890
165 New
165 $17 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $20.3B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Disciplina Capital Management LLC Portfolio

Follow Disciplina Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Disciplina Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Disciplina Capital Management LLC with notifications on news.